Hemophagocytic Lymphohistiocytosis

This is a rare group of diseases affecting the immune system. It involves too many lymphocytes and histiocytes (a type of immune cell) in the body, and sometimes these cells eat other blood cells. It can be inherited or caused by an infection.

Condition

What people with Hemophagocytic Lymphohistiocytosis report

Every report comes from a Lived member, sent anonymously.

Have you tried Etoposide for Hemophagocytic Lymphohistiocytosis?

NameHow it went

About Hemophagocytic Lymphohistiocytosis

What It Is

Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condition in which the immune system becomes overactivated and fails to switch itself off. Certain white blood cells, T lymphocytes and macrophages (also called histiocytes), keep multiplying and release large amounts of inflammatory signaling proteins called cytokines. The resulting inflammation causes persistent high fever, enlarges the liver and spleen, and damages the bone marrow, so counts of red blood cells, platelets and infection-fighting white cells fall. The name describes what doctors can see under the microscope: immune cells engulfing other blood cells, a process called hemophagocytosis. There are two broad forms. Primary, or familial, HLH is inherited and usually appears in infancy or early childhood, although it occasionally shows up later in life. Secondary, or acquired, HLH develops in response to an infection, a cancer or an autoimmune disease, and it is the more common form in adults. When it arises from a rheumatic disease such as Still's disease (including its childhood form, systemic juvenile idiopathic arthritis), it is usually called macrophage activation syndrome (MAS). Both forms can progress rapidly to organ failure, which is why early recognition and treatment matter so much.

Causes & Risk Factors

Familial HLH is caused by changes in genes that T cells and natural killer cells need to destroy virus-infected or abnormal cells. When that killing step fails, the immune cells stay switched on and inflammation escalates instead of settling down. Changes in two genes, those for the proteins perforin and Munc13-4, account for roughly 40 to 60 percent of familial cases; several other genes are known, and in some families no cause is found. Familial HLH is inherited in an autosomal recessive pattern: a child is affected when both parents pass on a changed copy of the same gene, and the parents themselves are usually healthy carriers. Some related inherited immune disorders that also disrupt this killing step, including X-linked lymphoproliferative disease, Chediak-Higashi syndrome and Griscelli syndrome type 2, also lead to HLH. In secondary HLH, an outside trigger sets off the runaway response. Infections are the most common trigger, and Epstein-Barr virus (EBV) is a well-known one, particularly in people with an inherited or acquired weakness of the immune system. Lymphoma and other cancers, and autoimmune or autoinflammatory diseases, are other important causes. Even in familial HLH, an infection often sets off the first episode. Why most people handle these triggers normally while a few develop HLH is only partly understood.

How It's Diagnosed

No single test confirms HLH. Doctors look for a pattern of findings: fever; an enlarged spleen; low counts in at least two types of blood cells; high triglycerides (a blood fat) or low fibrinogen (a clotting protein); signs of hemophagocytosis in bone marrow or other tissue; low or absent natural killer cell activity; a very high ferritin level; and a high level of soluble interleukin-2 receptor, a marker of immune activation. Under the widely used diagnostic criteria published in 2004 for an international HLH treatment study, five of these eight findings support the diagnosis, or a matching genetic result or family history can establish it on its own. Ferritin, a blood protein that rises sharply with this kind of inflammation, is one of the most useful early clues and is checked whenever HLH is suspected. Diagnosis is often difficult. HLH can look like a severe infection, sepsis or leukemia, and those criteria were developed for children and have not been validated in adults. Testing usually includes blood counts, liver tests, infection studies, a bone marrow aspirate and biopsy, imaging, and often a lumbar puncture (spinal tap) to check whether the brain is involved. Because treatment depends on what is driving the illness, doctors search at the same time for an infection, a cancer or a rheumatic disease, and genetic testing looks for an inherited form.

Treatment Options

HLH is treated urgently, usually in hospital by specialists in blood disorders, immunology or rheumatology. Treatment has two aims at the same time: calm the runaway inflammation before it damages organs, and treat whatever set it off. For familial HLH and severe EBV-associated HLH, the standard first treatment combines dexamethasone, a strong corticosteroid, with etoposide, a chemotherapy drug that clears out overactive immune cells. Cyclosporine, an immune-suppressing medicine, is part of some protocols, and medicine may be given into the spinal fluid when the brain is involved. These regimens have been lifesaving, but they suppress blood counts and immune defenses, so infections are a major risk during treatment. Because the standard protocols were designed for children, adults often receive lower doses or shorter courses to avoid unnecessary toxicity. Other options depend on the cause. Corticosteroids, anakinra (Kineret, a medicine that blocks the inflammatory signal interleukin-1) and intravenous immunoglobulin (IVIG, concentrated antibodies from donated blood, given by drip) are used early in suspected HLH and in macrophage activation syndrome. Emapalumab (Gamifant), an antibody that blocks the immune signal interferon gamma, is approved for primary HLH that does not respond to, returns after or cannot be tolerated with standard therapy, and for macrophage activation syndrome in Still's disease that has not responded adequately to steroids or keeps returning. It raises the risk of serious infections, so people are tested for tuberculosis before starting. Secondary HLH also requires treatment aimed at the trigger, such as medicines for the infection or treatment for an underlying cancer. For familial HLH, and for HLH that is severe, persistent or keeps returning, a hematopoietic stem cell transplant (bone marrow transplant) is recommended. It replaces the faulty immune system with blood-forming cells from a donor, and many people who have a successful transplant go on to lead full lives.

What to Expect

The first weeks are usually spent in hospital, sometimes in intensive care, with frequent blood tests and close monitoring for infection, bleeding and organ problems. With treatment, HLH may come under control within a few weeks, but it can flare again, especially as medicines are reduced, and further treatment may be needed. For people heading toward transplant, this period also involves finding a donor and preparing for a long recovery. The outlook depends heavily on the form and the trigger. Without treatment, most children with familial HLH survive only a few months; with treatment and transplant, many do well over the long term. In adults HLH remains very serious: in pooled studies, about half of adults diagnosed with HLH died, and about one in three had died within the first month. Outcomes tend to be worse when cancer is the trigger and at older ages, and better when HLH arises from a rheumatic disease. Follow-up continues for months after the acute illness, to watch for relapse and manage the effects of treatment or transplant. Because familial HLH is inherited, genetic counseling can help parents understand what the diagnosis means for brothers, sisters and future children.

When to Seek Help

Seek prompt medical assessment, the same day, for a fever that lasts for days without a clear explanation, especially with a rash, yellowing of the skin or eyes, a swollen belly from an enlarged liver or spleen, or blood tests showing falling counts. In a baby, unusual irritability alongside a persistent fever is also a reason for same-day assessment. Mention any family history of HLH, or a known rheumatic disease, lymphoma or recent EBV infection, since these raise the chance that HLH is the cause. During or after HLH treatment, contact the care team right away for any new fever or sign of infection, because treatment weakens defenses against infection and fever can also signal a flare. A seizure, new confusion or unusual drowsiness, or trouble breathing needs emergency care: call 911.

Questions to Ask Your Doctor

  1. 1.Is this primary (familial) or secondary HLH, and what do you think triggered it?
  2. 2.What does the treatment plan look like for the first weeks, and how will we know it is working?
  3. 3.Is a stem cell transplant recommended, and what would finding a donor and recovering involve?
  4. 4.Which signs of infection or a flare should we watch for at home, and who should we call?
  5. 5.Should other family members have genetic testing or counseling?

Last reviewed • Oct 2026

Educational content, not medical advice.